Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

NCT06179407 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated for business reasons

Conditions

Narcolepsy

Interventions

DRUG: MK-6552
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC